Skip to content

Clinical trials

Osteoporosis, Postmenopausal trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis, Postmenopausal Country / region: United States Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20025
20033
200415
20054
20067
20075
20081
20093
20102
20113
20127
20133
20143
20153
20163
20174
20185
20197
20217
20222
20232
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed88
Active, not recruiting6
Recruiting4
Terminated4
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company17
Hoffmann-La Roche11
Massachusetts General Hospital9
Amgen7
Radius Health, Inc.7
Sanofi4
Warner Chilcott4
Susan L. Greenspan3
Novartis Pharmaceuticals2
OHSU Knight Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis, Postmenopausal106
Osteoporosis39
Bone Diseases, Metabolic21
Fractures, Bone5
Osteoporotic Fractures5
Breast Neoplasms4
Musculoskeletal Diseases4
Bone Diseases3
Hyperparathyroidism, Primary2
Signs and Symptoms2

Trials

Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.